BIOLIGHT Life Sciences Investments Ltd.

News & Events

October 25, 2009 IOptima Receives European Patent Approval for its IOPtiMateTM Laser System October 25, 2009 IOPtima Launches OT-135 October 01, 2009 Dr. Floyd Taub Joins Zetiq Scientific Advisory Board September 23, 2009 Zetiq Team Publishes Article in Journal of Histotechnology August 10, 2009 IOPtima Receives CE Approval of its IOPtiMate(TM) Laser System for Treatment of Glaucoma

Bio-Light is a life sciences investment company, traded on the Tel Aviv Stock Exchange (TASE.)

Bio-Light holds three subsidiary companies which are managed independently, with Bio-Light supporting each company through its in-house multi-disciplinary team, offering expertise in science, intellectual property, regulation and business development.

ObeCure is developing safe and effective drugs for weight management.

IOptima is developing a non-penetrating glaucoma treatment using technology based on lasers.

Zetiq is developing diagnostic kits for the identification of cancerous cells.

© 2006 BIO-LIGHT Life Sciences Investments Ltd. Design by MWF	Bio-Light Ltd. - Israeli Life Sciences Investments Ltd. Paz Tower (9th floor) 5-7 Shoham St. 52521 Ramat-Gan , Israel Tel.: +972 (0)3 7534100 Fax: +972 (0)3 7515134